NO20011956L - Substituerte fenylderivater, deres fremstilling og anvendelse - Google Patents
Substituerte fenylderivater, deres fremstilling og anvendelseInfo
- Publication number
- NO20011956L NO20011956L NO20011956A NO20011956A NO20011956L NO 20011956 L NO20011956 L NO 20011956L NO 20011956 A NO20011956 A NO 20011956A NO 20011956 A NO20011956 A NO 20011956A NO 20011956 L NO20011956 L NO 20011956L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- substituted phenyl
- phenyl derivatives
- derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199801362 | 1998-10-22 | ||
| PCT/DK1999/000575 WO2000024707A1 (en) | 1998-10-22 | 1999-10-19 | Substituted phenyl derivatives, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011956L true NO20011956L (no) | 2001-04-20 |
| NO20011956D0 NO20011956D0 (no) | 2001-04-20 |
Family
ID=8104026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011956A NO20011956D0 (no) | 1998-10-22 | 2001-04-20 | Substituerte fenylderivater, deres fremstilling og anvendelse |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6706749B2 (no) |
| EP (2) | EP1123274B1 (no) |
| JP (2) | JP3960754B2 (no) |
| KR (1) | KR100799892B1 (no) |
| CN (1) | CN1263733C (no) |
| AP (1) | AP2001002103A0 (no) |
| AT (1) | ATE286021T1 (no) |
| AU (1) | AU759275B2 (no) |
| BR (1) | BR9914638A (no) |
| CA (1) | CA2342626A1 (no) |
| DE (1) | DE69922986T2 (no) |
| EE (1) | EE04849B1 (no) |
| ES (1) | ES2235522T3 (no) |
| HK (1) | HK1040699A1 (no) |
| HU (1) | HUP0103673A3 (no) |
| IL (2) | IL141479A0 (no) |
| IS (1) | IS2215B (no) |
| NO (1) | NO20011956D0 (no) |
| NZ (1) | NZ510098A (no) |
| OA (1) | OA11665A (no) |
| PL (1) | PL198852B1 (no) |
| PT (1) | PT1123274E (no) |
| RU (1) | RU2218328C2 (no) |
| SK (1) | SK5222001A3 (no) |
| TR (1) | TR200101126T2 (no) |
| UA (1) | UA73284C2 (no) |
| WO (1) | WO2000024707A1 (no) |
| ZA (1) | ZA200101824B (no) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10102977A1 (de) | 2001-01-23 | 2002-08-01 | Thomas Jentsch | Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose |
| JP2004522441A (ja) * | 2001-01-23 | 2004-07-29 | ノルディック・ビオサイエンス・エー／エス | 破骨細胞関連骨疾患を治療するための活性を目的として化合物を探索する方法 |
| WO2003000245A1 (en) * | 2001-06-22 | 2003-01-03 | Poseidon Pharmaceuticals A/S | Compounds for use in disorders associated with mast cell or basophil activity |
| EP1426762A4 (en) * | 2001-08-08 | 2007-05-09 | Chugai Pharmaceutical Co Ltd | DRUGS FOR CARDIAC DISEASES |
| US7078423B2 (en) | 2002-07-18 | 2006-07-18 | Inotek Pharmaceuticals Corporation | 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| US7087631B2 (en) | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
| US7291603B2 (en) | 2002-07-24 | 2007-11-06 | Ptc Therapeutics, Inc. | Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| CN1671378A (zh) * | 2002-08-01 | 2005-09-21 | 神经研究公司 | 用于治疗对抗血管生成疗法有应答的疾病的化合物 |
| WO2004022525A1 (en) * | 2002-09-05 | 2004-03-18 | Neurosearch A/S | Amide derivatives and their use as chloride channel blockers |
| DE60328202D1 (de) * | 2002-09-05 | 2009-08-13 | Neurosearch As | Diarylharnstoffderivate und deren verwendung als chloridkanalblocker |
| JP2006507329A (ja) | 2002-11-21 | 2006-03-02 | ニューロサーチ、アクティーゼルスカブ | 新規アリールウレイド安息香酸誘導体及びその使用 |
| US20060229335A1 (en) * | 2002-12-24 | 2006-10-12 | Bradley Teegarden | Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| EP1638948B1 (en) | 2003-06-17 | 2008-10-15 | Neurosearch A/S | Diphenylurea derivatives and their use as chloride channel blockers |
| EA009732B1 (ru) | 2003-07-22 | 2008-02-28 | Арена Фармасьютикалз, Инк. | Диарильные и арилгетероарильные производные мочевины в качестве модуляторов 5-ht-рецептора серотонина, пригодные для профилактики и лечения связанных с ним заболеваний |
| WO2005023238A1 (en) * | 2003-09-04 | 2005-03-17 | Poseidon Pharmaceuticals A/S | Erg channel openers for the treatment of hyperexcitability-related neuronal diseases |
| CN1845726A (zh) | 2003-09-04 | 2006-10-11 | 波塞东医药公司 | 用于治疗心脏心律失常的erg通道开放剂 |
| CN1926114B (zh) * | 2004-03-23 | 2011-08-24 | 艾尼纳制药公司 | 用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法 |
| DK1737831T3 (da) | 2004-04-02 | 2013-08-19 | Prana Biotechnology Ltd | Neurologisk aktive forbindelser |
| MXPA06012603A (es) * | 2004-05-12 | 2007-04-12 | Proteotech Inc | Benzamidas de n-arilo sustituidas y compuestos relacionados para el tratamiento de enfermedades amiloides y sinucleinopatias. |
| PE20061130A1 (es) | 2004-11-19 | 2007-01-05 | Arena Pharm Inc | Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a |
| WO2006060762A2 (en) * | 2004-12-03 | 2006-06-08 | Arena Pharmaceuticals, Inc. | Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
| PL1858877T3 (pl) | 2005-01-14 | 2014-08-29 | Gilead Connecticut Inc | 1,3 podstawione diarylem moczniki jako modulatory aktywności kinazy |
| CN101160127A (zh) * | 2005-01-19 | 2008-04-09 | 艾尼纳制药公司 | 用于预防或治疗进行性多灶性白质脑病而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物 |
| WO2007024294A2 (en) | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| US7985761B2 (en) | 2006-03-14 | 2011-07-26 | Neurosearch A/S | Diphenylurea derivatives and their use as chloride channel blockers or BKCa channel modulators |
| BRPI0710737A2 (pt) | 2006-04-14 | 2011-05-10 | Prana Biotechnology Ltd | uso de compostos pb-10 33 éteis para o tratamento de degeneraÇço macular relacionada À idade (amd), assim como referidos compostos |
| EP2018371B1 (en) | 2006-05-18 | 2015-03-04 | Arena Pharmaceuticals, Inc. | Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| EP3395816A1 (en) | 2006-05-18 | 2018-10-31 | Arena Pharmaceuticals, Inc. | Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| NZ571829A (en) | 2006-05-18 | 2011-10-28 | Arena Pharm Inc | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| JP5393677B2 (ja) | 2007-08-15 | 2014-01-22 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体 |
| EP2212303A1 (en) * | 2007-11-26 | 2010-08-04 | NeuroSearch AS | Novel benzamide derivatives useful as potassium channel modulators |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9034911B2 (en) | 2008-10-28 | 2015-05-19 | Arena Pharmaceuticals, Inc. | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| WO2011022028A2 (en) * | 2009-05-18 | 2011-02-24 | Tufts University | Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof |
| GB0915196D0 (en) | 2009-09-01 | 2009-10-07 | King S College London | Therapeutic compounds and their use |
| US8980891B2 (en) | 2009-12-18 | 2015-03-17 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| US20120208855A1 (en) * | 2010-07-12 | 2012-08-16 | Sanofi | Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders |
| US9834537B2 (en) | 2013-11-27 | 2017-12-05 | Korea Institute Of Science And Technology | Compounds as chloride channel blocking agent |
| WO2016001452A1 (en) * | 2014-07-04 | 2016-01-07 | Universität Zürich | Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated |
| EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
| BR112018000728A2 (pt) | 2015-07-15 | 2018-09-04 | Axovant Sciences Gmbh | resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo |
| PT3622953T (pt) | 2016-05-17 | 2021-04-21 | Scandion Oncology As | Tratamento combinado do cancro |
| JOP20200001A1 (ar) | 2017-07-11 | 2022-10-30 | Vertex Pharma | كاربوكسأميدات بوصفها معدلات لقنوات الصوديوم |
| CA3194203A1 (en) * | 2020-09-14 | 2022-03-17 | Genzyme Corporation | Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell disease |
| CA3221556A1 (en) | 2021-06-14 | 2022-12-22 | Scandion Oncology A/S | Combination treatments for cancer patients and methods for identifying same |
| EP4355322A1 (en) | 2021-06-14 | 2024-04-24 | Scandion Oncology A/S | Methods of increasing the plasma drug exposure of anticancer agents |
| EP4104834A1 (en) | 2021-06-14 | 2022-12-21 | Scandion Oncology A/S | Combination treatments for cancer patients and methods for identifying same |
| TW202321205A (zh) | 2021-07-16 | 2023-06-01 | 丹麥商斯坎丁腫瘤公司 | Sco-101的熱力穩定形式 |
| CN117229258A (zh) * | 2022-06-07 | 2023-12-15 | 杭州壹瑞医药科技有限公司 | N-四唑基芳基脲类衍生物及其制备方法和应用 |
| WO2024013058A1 (en) | 2022-07-11 | 2024-01-18 | Scandion Oncology A/S | Salts of sco-101 and methods involving salts |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1055786A (en) * | 1963-07-12 | 1967-01-18 | Ici Ltd | Urea derivatives |
| FR2100943A1 (en) * | 1970-07-23 | 1972-03-24 | Ici Ltd | O-carboylcarbanilides from anthranilic acid and substd - isocyanates - immuno-suppressive agents |
| DE2928485A1 (de) * | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
| CA1156250A (en) * | 1979-10-15 | 1983-11-01 | Eastman Kodak Company | Cyan dye-forming couplers |
| EP0210574B1 (de) | 1985-07-31 | 1991-10-23 | Hoechst Aktiengesellschaft | N-Substituierte 5-Nitroanthranilsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen |
| US4889612A (en) | 1987-05-22 | 1989-12-26 | Abbott Laboratories | Ion-selective electrode having a non-metal sensing element |
| US4921997A (en) * | 1988-06-15 | 1990-05-01 | Montefiore Medical Center | Method of synthesis and novel compounds for pharmaceutical uses |
| AU650261B2 (en) | 1990-03-07 | 1994-06-16 | Rhone-Poulenc Rorer S.A. | Derivatives of glycinamide, their preparation and medicaments containing them |
| US5489612A (en) | 1991-08-23 | 1996-02-06 | The University Of Alabama At Birmingham Research Foundation | Calixarene chloride-channel blockers |
| US5273992A (en) | 1992-11-02 | 1993-12-28 | Beth Israel Hospital Assoc. Inc. | Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ |
| DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
| CA2137755C (en) * | 1994-06-07 | 2002-07-02 | William H. Waugh | Palliation of sickle cell disorders by phenylurea, benzylurea, or phenylethylurea or by a homolog ring-substituted with one methoxyl, methyl, or hydroxyl radical |
| US5559151A (en) | 1994-11-30 | 1996-09-24 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers |
| DE4447096C2 (de) * | 1994-12-29 | 1998-12-03 | Rehau Ag & Co | Stabilisierte chlorhaltige Polymerisate und Verwendung von funktionellen Harnstoff-Derivaten als Stabilisatoren |
| EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
| US5773459A (en) * | 1995-06-07 | 1998-06-30 | Sugen, Inc. | Urea- and thiourea-type compounds |
| TR199802136T2 (xx) * | 1996-04-23 | 2001-06-21 | Vertex Pharmaceuticals Incorporated | �MPDH enzimi inhibit�rleri olarak �re t�revleri. |
| WO1997045400A1 (en) * | 1996-05-24 | 1997-12-04 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| NZ337976A (en) * | 1997-04-22 | 2001-05-25 | Neurosearch As | Substituted phenyl derivatives, their preparation and use |
| US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| ES2154252T3 (es) * | 1997-12-22 | 2005-12-01 | Bayer Pharmaceuticals Corp. | Inhibicion de quinasa p38 utilizando difenil-ureas simetricas y asimetricas. |
-
1999
- 1999-10-19 SK SK522-2001A patent/SK5222001A3/sk unknown
- 1999-10-19 KR KR1020017004970A patent/KR100799892B1/ko not_active IP Right Cessation
- 1999-10-19 RU RU2001107853/04A patent/RU2218328C2/ru not_active IP Right Cessation
- 1999-10-19 IL IL14147999A patent/IL141479A0/xx active IP Right Grant
- 1999-10-19 ZA ZA200101824A patent/ZA200101824B/en unknown
- 1999-10-19 CN CNB998117730A patent/CN1263733C/zh not_active Expired - Fee Related
- 1999-10-19 DE DE69922986T patent/DE69922986T2/de not_active Expired - Lifetime
- 1999-10-19 OA OA1200100094A patent/OA11665A/en unknown
- 1999-10-19 CA CA002342626A patent/CA2342626A1/en not_active Abandoned
- 1999-10-19 NZ NZ510098A patent/NZ510098A/en unknown
- 1999-10-19 TR TR2001/01126T patent/TR200101126T2/xx unknown
- 1999-10-19 HU HU0103673A patent/HUP0103673A3/hu unknown
- 1999-10-19 EP EP99950505A patent/EP1123274B1/en not_active Expired - Lifetime
- 1999-10-19 AT AT99950505T patent/ATE286021T1/de not_active IP Right Cessation
- 1999-10-19 UA UA2001021084A patent/UA73284C2/uk unknown
- 1999-10-19 WO PCT/DK1999/000575 patent/WO2000024707A1/en active IP Right Grant
- 1999-10-19 EP EP04105861A patent/EP1514867A3/en not_active Withdrawn
- 1999-10-19 AU AU63259/99A patent/AU759275B2/en not_active Ceased
- 1999-10-19 PL PL347371A patent/PL198852B1/pl unknown
- 1999-10-19 BR BR9914638-0A patent/BR9914638A/pt not_active Application Discontinuation
- 1999-10-19 JP JP2000578279A patent/JP3960754B2/ja not_active Expired - Fee Related
- 1999-10-19 EE EEP200100185A patent/EE04849B1/xx not_active IP Right Cessation
- 1999-10-19 ES ES99950505T patent/ES2235522T3/es not_active Expired - Lifetime
- 1999-10-19 PT PT99950505T patent/PT1123274E/pt unknown
- 1999-10-19 AP APAP/P/2001/002103A patent/AP2001002103A0/en unknown
-
2001
- 2001-02-16 IL IL141479A patent/IL141479A/en not_active IP Right Cessation
- 2001-03-02 IS IS5875A patent/IS2215B/is unknown
- 2001-04-19 US US09/837,166 patent/US6706749B2/en not_active Expired - Fee Related
- 2001-04-20 NO NO20011956A patent/NO20011956D0/no not_active Application Discontinuation
-
2002
- 2002-03-19 HK HK02102082A patent/HK1040699A1/xx not_active IP Right Cessation
-
2003
- 2003-01-30 JP JP2003022576A patent/JP2003246773A/ja not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20011956D0 (no) | Substituerte fenylderivater, deres fremstilling og anvendelse | |
| NO20015156L (no) | 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse | |
| NO20014603D0 (no) | Tienopyrimidinforbindelser, deres fremstilling og anvendelse | |
| NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
| DK1073672T3 (da) | Antipicornavirale forbindelser, deres fremstilling og anvendelse | |
| NO20024742L (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse | |
| NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
| NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
| NO20015113L (no) | Nye forbindelser, deres fremstilling og anvendelse | |
| DK1083171T3 (da) | Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter | |
| DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
| NO20006460L (no) | 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse | |
| NO20023146D0 (no) | Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse | |
| DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
| NO20001934D0 (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| NO20013085D0 (no) | Fosfororganiske forbindelser og deres anvendelse | |
| NO20006479D0 (no) | Tienopyridinforbindelser, deres fremstilling og anvendelse | |
| NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
| NO20012802D0 (no) | Benzofuranderivater, deres fremstilling og anvendelse | |
| NO20025209L (no) | Cyklipostiner, deres fremstilling og anvendelse | |
| NO996156L (no) | Substituerte cykloheptener, deres fremstilling og anvendelse | |
| NO20001782D0 (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
| DK1123274T3 (da) | Substituerede phenylderivater, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |